Regencell Bioscience Holdings (RGC) Retained Earnings (2020 - 2025)
Regencell Bioscience Holdings' (RGC) quarterly Retained Earnings came in at -$30.5 million in Q4 2025, down 21.1% on a QoQ basis from -$25.2 million in Q2 2025.
Regencell Bioscience Holdings (RGC) Retained Earnings (2020 - 2025) Analysis & Trends
Regencell Bioscience Holdings (RGC) has 6 years of Retained Earnings data on file, last reported at -$30.5 million in Q4 2025.
- Quarterly Retained Earnings changed N/A year-over-year to -$30.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$30.5 million (changed N/A YoY) and the FY2025 annual result came in at -$25.2 million, down 16.58% from the prior year.
- Retained Earnings fell to -$30.5 million in Q4 2025, from -$25.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$4.0 million in Q2 2021 to a low of -$30.5 million in Q4 2025.
- A 5-year average of -$18.3 million and a median of -$19.5 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings slumped 186.24% — and 2025, when it declined 16.58%.
- Tracing RGC's Retained Earnings over 5 years: stood at -$4.0 million in 2021, then sank by 186.24% to -$11.4 million in 2022, then tumbled by 51.3% to -$17.3 million in 2023, then dropped by 24.84% to -$21.6 million in 2024, then slumped by 41.18% to -$30.5 million in 2025.
- The last three Retained Earnings figures came in at -$30.5 million (Q4 2025), -$25.2 million (Q2 2025), and -$21.6 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Regencell Bioscience Holdings | 2.61 Bn | 2.61 Bn | - | -30.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30.52 Mn |
| Jun 30, 2025 | -25.20 Mn |
| Jun 30, 2024 | -21.62 Mn |
| Jun 30, 2023 | -17.32 Mn |
| Jun 30, 2022 | -11.44 Mn |
| Jun 30, 2021 | -4.00 Mn |
| Jun 30, 2020 | -2.65 Mn |